tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CLEO Diagnostics Ltd Seeks ASX Quotation for New Securities

Story Highlights
CLEO Diagnostics Ltd Seeks ASX Quotation for New Securities

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

CLEO Diagnostics Ltd ( (AU:COV) ) has provided an update.

CLEO Diagnostics Ltd has announced the application for the quotation of 46,900,000 ordinary fully paid securities on the Australian Securities Exchange (ASX), under the code COV. This move indicates the company’s efforts to enhance its market presence and potentially increase its capital base, which could have significant implications for its operations and stakeholders.

More about CLEO Diagnostics Ltd

Average Trading Volume: 132,768

Technical Sentiment Signal: Strong Buy

For a thorough assessment of COV stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1